Shire plc 4 SEC Filings

Filed On	Filing
02 Jul 2018	Form 4: Shire Human Genetic Therapies, Inc., 10% owner and 1 other · Translate Bio, Inc. Acquired 183,619 shares (Other Transaction)
22 Nov 2004	Form 4: Cavanaugh James H, Director Sold 10,000 shares ($300K)
12 Nov 2004	Form 4: Cavanaugh James H, Director Acquired 270,277 shares (Other Transaction)
02 Jun 2004	Form 4: Shire Biochem Inc, 10% owner and 1 other · ImmunoGen, Inc. Sold 4,030,000 shares ($27.1M)

Comments